A Clinical study on â??Raththa sogai"(Anaemia) with trial drug â??Mandoora Chooranamâ??

An open Pilot Clinical study on â??Pitha Paanduâ?? (Iron deficiency anaemia) with the evaluation of trial drug â??Mandoora Chooranamâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/08/004930

Enrollment

Registered

2014-08-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- MALE AND FEMALE WITH ANAEMIA (IRON DEFICIENCY)

Interventions

Intervention1: MANDOORA CHOORANAM: 1gm,b.d with butter milk by oral route for 48 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Age 12-60years Hb 8-10 gms% Fatigue Loss of appetite Pallor of conjunctiva and nail bed Dyspnea on exertion Ulceration of mouth Worm Infestation

Exclusion criteria

Exclusion criteria: History of chronic Renal disorders History of chronic Liver disorders History of Thalessemia History of Bleeding disorder History of Myxoedema History of Pancytopenia Vulnerable Populations such as pregnant women, Lactating mothers, TB affected individuals, HIV positive.

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction in clinical symptoms and by comparing the following parameters before and after treatment. 1. Complete Hemogram(HB, PCV,MCV, MCHC, TIBC, SERUM FERRITIN) Timepoint: 48 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatment.Timepoint: 48 days	—

Countries

India

Contacts

Public ContactPROF Dr P PARTHIBAN MD S

GOVERNMENT SIDDHA MEDICAL COLLEGE

drkkanakavalli@gmail.com9444122865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026